{"id":28285,"date":"2026-05-12T14:44:12","date_gmt":"2026-05-12T21:44:12","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=28285"},"modified":"2026-05-12T14:53:09","modified_gmt":"2026-05-12T21:53:09","slug":"sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/","title":{"rendered":"Sevenfact: Una nueva opci\u00f3n de tratamiento para la hemofilia con inhibidores"},"content":{"rendered":"<p>Sevenfact es un medicamento aprobado por la FDA que se utiliza para tratar o controlar el sangrado en pacientes con <a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/hemophilia-a-vs-b-whats-the-difference\/\">hemofilia A o B<\/a> con inhibidores. En este art\u00edculo, aprender\u00e1 sobre su mecanismo de acci\u00f3n, dosis, efectos secundarios, costo y m\u00e1s.<\/p>\n\n\n\n<div  id=\"call-to-action-707b01b6ede6cdf1180a7772e6c7278c\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#What_Is_Sevenfact\" >\u00bfQu\u00e9 es Sevenfact?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#What_Is_Sevenfact_Used_For\" >\u00bfPara qu\u00e9 se utiliza Sevenfact?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Sevenfact_Mechanism_of_Action\" >Mecanismo de acci\u00f3n de Sevenfact<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Sevenfact_Dosing\" >Dosificaci\u00f3n de Sevenfact<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Recommended_Sevenfact_Dosing\" >Dosis recomendada de Sevenfact:<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Sevenfact_Side_Effects\" >Siete datos sobre efectos secundarios<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Common_Side_Effects\" >Efectos secundarios comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Serious_Side_Effects\" >Efectos secundarios graves<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Allergic_Reactions\" >Reacciones al\u00e9rgicas<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Warnings_and_Precautions\" >Advertencias y precauciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Before_Using_Sevenfact\" >Antes de usar Sevenfact<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Sevenfact_vs_NovoSeven\" >Sevenfact vs. NovoSeven<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#Sevenfact_Cost\" >Costo de Sevenfact<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Sevenfact\"><\/span>\u00bfQu\u00e9 es Sevenfact?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Sevenfact es un medicamento de marca que requiere receta m\u00e9dica. El ingrediente activo de este producto es el factor de coagulaci\u00f3n VIIa (recombinante)-jncw, tambi\u00e9n llamado eptacog beta.&nbsp;<\/p>\n\n\n\n<p>Sevenfact pertenece a una clase de medicamentos conocidos como <a href=\"https:\/\/www.bd.com\/en-us\/products-and-solutions\/products\/product-families\/hemostatic-agent\">hemost\u00e1ticos<\/a>.<\/p>\n\n\n\n<p>El t\u00e9rmino \u201crecombinante\u201d significa que este medicamento se fabrica en un laboratorio utilizando tecnolog\u00eda de ADN recombinante. Las cuatro letras min\u00fasculas \u201cjncw\u201d se utilizan para distinguir Sevenfact de otros productos similares.&nbsp;<\/p>\n\n\n\n<p>La FDA estadounidense aprob\u00f3 Sevenfact en abril de 2020 para tratar y controlar las hemorragias en personas de 12 a\u00f1os o m\u00e1s con hemofilia A o B con inhibidores.&nbsp;<\/p>\n\n\n\n<p>Este producto no debe utilizarse para tratar a personas con deficiencia cong\u00e9nita del factor VII.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Sevenfact_Used_For\"><\/span>\u00bfPara qu\u00e9 se utiliza Sevenfact?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Sevenfact se utiliza para tratar y controlar los episodios de sangrado en pacientes con hemofilia A o B que han desarrollado inhibidores a los tratamientos est\u00e1ndar con factores de coagulaci\u00f3n.<\/p>\n\n\n\n<p>Los inhibidores son <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/immunoglobulins-ig\/\">anticuerpos<\/a> que se desarrollan en algunos pacientes y bloquean los tratamientos est\u00e1ndar con factores de coagulaci\u00f3n, lo que dificulta el control del sangrado.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sevenfact_Mechanism_of_Action\"><\/span>Mecanismo de acci\u00f3n de Sevenfact<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El factor de coagulaci\u00f3n recombinante VIIa (rFVIIa) presente en Sevenfact ayuda a la sangre a coagularse activando otro factor de coagulaci\u00f3n llamado factor X.&nbsp;<\/p>\n\n\n\n<p>Normalmente, la activaci\u00f3n del Factor X depende de los Factores VIII y IX. Sevenfact evita esta v\u00eda, permitiendo la formaci\u00f3n de co\u00e1gulos incluso en ausencia de estos factores. Por esta raz\u00f3n, se le conoce como un \u201cagente de derivaci\u00f3n\u201d.\u201d<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sevenfact_Dosing\"><\/span>Dosificaci\u00f3n de Sevenfact<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Este medicamento se presenta en forma de polvo de color blanco a blanquecino para soluci\u00f3n (reconstituci\u00f3n) para inyecci\u00f3n intravenosa (IV) en viales monodosis.&nbsp;<\/p>\n\n\n\n<p>Las siguientes concentraciones est\u00e1n disponibles en EE. UU.:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>1 mg de factor de coagulaci\u00f3n VIIa (recombinante)-jncw<\/li>\n\n\n\n<li>2 mg de factor de coagulaci\u00f3n VIIa (recombinante)-jncw<\/li>\n\n\n\n<li>5 mg de factor de coagulaci\u00f3n VIIa (recombinante)-jncw<\/li>\n<\/ul>\n\n\n\n<p>El l\u00edquido para preparar la soluci\u00f3n viene en jeringas de vidrio precargadas de dosis \u00fanica. Cada jeringa contiene 1,1 ml, 2,2 ml o 5,2 ml de agua est\u00e9ril para inyecci\u00f3n.&nbsp;<\/p>\n\n\n\n<p>La dosis y la duraci\u00f3n del tratamiento dependen de:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ubicaci\u00f3n y gravedad del sangrado<\/li>\n\n\n\n<li>Necesidad de control urgente de la hemorragia<\/li>\n\n\n\n<li>Frecuencia de administraci\u00f3n<\/li>\n\n\n\n<li>Respuesta a los agentes de derivaci\u00f3n durante episodios hemorr\u00e1gicos previos<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recommended_Sevenfact_Dosing\"><\/span>Dosis recomendada de Sevenfact:<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Sangrado leve y moderado<\/strong>:<strong> <\/strong>Se administra una dosis de 75 mcg\/kg cada 3 horas hasta que cese la hemorragia. Como alternativa, se puede utilizar una dosis inicial de 225 mcg\/kg. Si la hemorragia no cesa en 9 horas, se puede administrar una dosis adicional de 75 mcg\/kg cada 3 horas seg\u00fan sea necesario para detenerla.<\/p>\n\n\n\n<p>Si el sangrado no se detiene dentro de las 24 horas posteriores a la primera dosis, es probable que su m\u00e9dico le recete un tratamiento alternativo.&nbsp;<\/p>\n\n\n\n<p><strong>sangrado severo<\/strong>Dosis inicial: 225 mcg\/kg. Si es necesario despu\u00e9s de 6 horas, administrar 75 mcg\/kg cada 2 horas hasta que cese el sangrado.<\/p>\n\n\n\n<p>La duraci\u00f3n del tratamiento depende de la localizaci\u00f3n y la gravedad de la hemorragia.&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-f1bd45a46b42e1e45e32ec816572473e\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfCalifica usted para el copago $0?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tHable con un especialista para averiguarlo\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una llamada<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sevenfact_Side_Effects\"><\/span>Siete datos sobre efectos secundarios<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Common_Side_Effects\"><\/span>Efectos secundarios comunes<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect.jpg\" alt=\"Patient with fever, a side effect of taking Sevenfact\" class=\"wp-image-28287\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/sevenfact-side-effect-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<ul class=\"wp-block-list\">\n<li>Dolor de cabeza<\/li>\n\n\n\n<li>Mareo<\/li>\n\n\n\n<li>Dolor, enrojecimiento o hinchaz\u00f3n en el lugar de la infusi\u00f3n.<\/li>\n\n\n\n<li>Fiebre<\/li>\n\n\n\n<li>Dolor articular<\/li>\n\n\n\n<li>Picaz\u00f3n leve&nbsp;<\/li>\n\n\n\n<li>N\u00e1useas&nbsp;<\/li>\n\n\n\n<li>V\u00f3mitos&nbsp;<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Serious_Side_Effects\"><\/span>Efectos secundarios graves<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Llame a su proveedor de atenci\u00f3n m\u00e9dica de inmediato si experimenta alguno de los siguientes s\u00edntomas:<\/p>\n\n\n\n<p><strong>Ataque<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Entumecimiento o debilidad repentinos<\/li>\n\n\n\n<li>Dolor de cabeza severo<\/li>\n\n\n\n<li>Habla arrastrada<\/li>\n\n\n\n<li>Dificultad con la visi\u00f3n o el equilibrio<\/li>\n<\/ul>\n\n\n\n<p><strong>Co\u00e1gulo de sangre en el pulm\u00f3n<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dolor en el pecho<\/li>\n\n\n\n<li>Tos repentina o dificultad para respirar<\/li>\n\n\n\n<li>Mareo<\/li>\n\n\n\n<li>Tos con sangre<\/li>\n<\/ul>\n\n\n\n<p><strong>Co\u00e1gulo de sangre en lo profundo del cuerpo<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dolor, hinchaz\u00f3n o calor en una de las piernas.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allergic_Reactions\"><\/span>Reacciones al\u00e9rgicas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Este medicamento puede causar reacciones al\u00e9rgicas que pueden ser mortales. Busque atenci\u00f3n m\u00e9dica de emergencia si experimenta:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Urticaria<\/li>\n\n\n\n<li>dificultad para respirar<\/li>\n\n\n\n<li>Hinchaz\u00f3n en la cara o la garganta<\/li>\n\n\n\n<li>Opresi\u00f3n en el pecho<\/li>\n\n\n\n<li>ritmo card\u00edaco acelerado<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Warnings_and_Precautions\"><\/span>Advertencias y precauciones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Este medicamento puede causar reacciones graves o potencialmente mortales. Llame a su m\u00e9dico de inmediato si experimenta alguno de los siguientes s\u00edntomas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Urticaria, picaz\u00f3n o sarpullido<\/li>\n\n\n\n<li>Dolor o opresi\u00f3n en el pecho<\/li>\n\n\n\n<li>Dificultad para respirar<\/li>\n\n\n\n<li>sibilancias<\/li>\n\n\n\n<li>Mareo<\/li>\n\n\n\n<li>Presi\u00f3n arterial baja<\/li>\n\n\n\n<li>Dolor, hinchaz\u00f3n y calor en una pierna.<\/li>\n\n\n\n<li>Entumecimiento o debilidad repentina (que afecta especialmente a un lado del cuerpo).<\/li>\n\n\n\n<li>Dolor de cabeza severo<\/li>\n\n\n\n<li>Habla arrastrada<\/li>\n\n\n\n<li>Problemas con la visi\u00f3n o el equilibrio<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-0559d6464b948e20d1d6d193a7960d77\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Before_Using_Sevenfact\"><\/span>Antes de usar Sevenfact<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>No debe usar este medicamento si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Antecedentes de reacciones al\u00e9rgicas a conejos o prote\u00ednas de conejo.<\/li>\n\n\n\n<li>\u00bfEs al\u00e9rgico a este producto o a alguno de sus componentes?<\/li>\n<\/ul>\n\n\n\n<p>Antes de recibir su primera dosis de Sevenfact, informe a su m\u00e9dico si tiene o ha tenido alguna vez:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/coronary-artery-disease\/symptoms-causes\/syc-20350613\">Arteriopat\u00eda coronaria<\/a> (estrechamiento de las arterias que suministran ox\u00edgeno al coraz\u00f3n)<\/li>\n\n\n\n<li>Ataque card\u00edaco o accidente cerebrovascular<\/li>\n\n\n\n<li>Lesi\u00f3n o infecci\u00f3n grave<\/li>\n\n\n\n<li>Reacciones al\u00e9rgicas a las prote\u00ednas de rat\u00f3n, h\u00e1mster o vaca.<\/li>\n\n\n\n<li>Enfermedad hep\u00e1tica<\/li>\n<\/ul>\n\n\n\n<p>Adem\u00e1s, informe a su proveedor de atenci\u00f3n m\u00e9dica si usted:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Embarazada o planeando quedar embarazada<\/li>\n\n\n\n<li>Amamantar o planea amamantar<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sevenfact_vs_NovoSeven\"><\/span>Sevenfact vs. NovoSeven<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Siete datos y <a href=\"https:\/\/www.novosevenrt.com\/\">NovoSeven<\/a> son factores de coagulaci\u00f3n. Las diferencias se enumeran a continuaci\u00f3n:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Caracter\u00edsticas<\/strong><\/td><td><strong>Siete datos<\/strong><\/td><td><strong>NovoSeven<\/strong><\/td><\/tr><tr><td>Uso autorizado&nbsp;<\/td><td>Hemofilia A o B con inhibidores en adultos y adolescentes de 12 a\u00f1os o m\u00e1s.&nbsp;<\/td><td>Adultos y ni\u00f1os con hemofilia A o B con inhibidores, deficiencia cong\u00e9nita del factor VII. Adultos con hemofilia adquirida.&nbsp;<\/td><\/tr><tr><td>Fecha de aprobaci\u00f3n de la FDA<\/td><td>2020<\/td><td>1999<\/td><\/tr><tr><td>Ingrediente activo&nbsp;<\/td><td>Eptacog beta&nbsp;<\/td><td>eptacog alfa<\/td><\/tr><tr><td>Fortalezas disponibles&nbsp;<\/td><td>1 mg, 2 mg y 5 mg de factor de coagulaci\u00f3n VIIa (recombinante)-jncw&nbsp;<\/td><td>1 mg, 2 mg, 5 mg u 8 mg de factor de coagulaci\u00f3n VIIa recombinante (FVIIa)<\/td><\/tr><tr><td>Fabricante&nbsp;<\/td><td>Productos biol\u00f3gicos HEMA&nbsp;<\/td><td>Novo Nordisk Limited<\/td><\/tr><tr><td>Contraindicaciones<\/td><td>Alergia conocida a los conejos o a las prote\u00ednas de conejo. Alergia grave a este producto o a cualquiera de sus componentes.<\/td><td>Ninguno<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sevenfact_Cost\"><\/span>Costo de Sevenfact<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El costo puede variar seg\u00fan su seguro m\u00e9dico, ubicaci\u00f3n y farmacia. Comun\u00edquese con su aseguradora para averiguar si su plan cubre este medicamento o si necesita autorizaci\u00f3n previa.<\/p>\n\n\n\n<p>El fabricante de Sevenfact, HEMA Biologics, ofrece varios servicios de apoyo a trav\u00e9s de su programa \u201cHEMA Biologics Cares\u201d para pacientes elegibles. Estos incluyen:<\/p>\n\n\n\n<p><strong>Programa de ahorro en copagos de Sevenfact<\/strong><\/p>\n\n\n\n<p>Los pacientes que cumplan los requisitos podr\u00e1n recibir hasta 12.000 T en ahorros por a\u00f1o natural a trav\u00e9s de HEMA Biologics Cares.&nbsp;<\/p>\n\n\n\n<p><strong>Programa de Asistencia al Paciente (PAP)<\/strong>&nbsp;<\/p>\n\n\n\n<p>El Programa de Asistencia al Paciente (PAP, por sus siglas en ingl\u00e9s) proporciona este medicamento sin costo alguno si los pacientes cumplen con requisitos de ingresos espec\u00edficos.&nbsp;<\/p>\n\n\n\n<p><strong>Programa de inicio r\u00e1pido<\/strong><\/p>\n\n\n\n<p>Este programa est\u00e1 dirigido a nuevos usuarios que est\u00e1n experimentando retrasos en la recepci\u00f3n de su tratamiento debido a problemas con su cobertura de seguro.&nbsp;<\/p>\n\n\n\n<p><strong>Programa puente<\/strong><\/p>\n\n\n\n<p>Este programa est\u00e1 dirigido a usuarios actuales que est\u00e1n experimentando retrasos en la recepci\u00f3n de su tratamiento debido a cambios en su cobertura de seguro.&nbsp;<\/p>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">Cont\u00e1ctanos<\/a> si est\u00e1 interesado en explorar oportunidades de asistencia financiera o <a href=\"https:\/\/ameripharmaspecialty.com\/es\/sevenfact-copay-assistance\/\">Asistencia para el copago de Sevenfact<\/a>.\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Sevenfact es un medicamento aprobado por la FDA que se utiliza para tratar o controlar el sangrado en pacientes con hemofilia A o B con inhibidores. En este art\u00edculo, encontrar\u00e1 informaci\u00f3n sobre su mecanismo de acci\u00f3n, dosis, efectos secundarios, costo y m\u00e1s.<\/p>","protected":false},"author":25,"featured_media":28286,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[6],"tags":[31],"class_list":["post-28285","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hemophilia","tag-dr-mark-alfonso"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sevenfact: A New Treatment Option for Hemophilia With Inhibitors - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about Sevenfact, an FDA-approved treatment for hemophilia A or B with inhibitors, including dosage, side effects, cost, and safety info.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sevenfact: A New Treatment Option for Hemophilia With Inhibitors - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about Sevenfact, an FDA-approved treatment for hemophilia A or B with inhibitors, including dosage, side effects, cost, and safety info.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-12T21:44:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-12T21:53:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/\"},\"author\":{\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\"},\"headline\":\"Sevenfact: A New Treatment Option for Hemophilia With Inhibitors\",\"datePublished\":\"2026-05-12T21:44:12+00:00\",\"dateModified\":\"2026-05-12T21:53:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/\"},\"wordCount\":1020,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/doctor-hemophilia.jpg\",\"keywords\":[\"Dr. Mark Alfonso\"],\"articleSection\":[\"Hemophilia\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/\",\"name\":\"Sevenfact: A New Treatment Option for Hemophilia With Inhibitors - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/doctor-hemophilia.jpg\",\"datePublished\":\"2026-05-12T21:44:12+00:00\",\"dateModified\":\"2026-05-12T21:53:09+00:00\",\"description\":\"Learn about Sevenfact, an FDA-approved treatment for hemophilia A or B with inhibitors, including dosage, side effects, cost, and safety info.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/doctor-hemophilia.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/doctor-hemophilia.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Doctor seeing a boy and parent about hemophilia and Sevenfact\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sevenfact: A New Treatment Option for Hemophilia With Inhibitors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\",\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"caption\":\"Dr. Mark Alfonso, PharmD, BCMTMS\"},\"description\":\"Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/mark-alfonso\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sevenfact: Una nueva opci\u00f3n de tratamiento para la hemofilia con inhibidores - AmeriPharma\u00ae Specialty Care","description":"Inf\u00f3rmese sobre Sevenfact, un tratamiento aprobado por la FDA para la hemofilia A o B con inhibidores, incluyendo informaci\u00f3n sobre la dosis, los efectos secundarios, el costo y la seguridad.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/","og_locale":"es_MX","og_type":"article","og_title":"Sevenfact: A New Treatment Option for Hemophilia With Inhibitors - AmeriPharma\u00ae Specialty Care","og_description":"Learn about Sevenfact, an FDA-approved treatment for hemophilia A or B with inhibitors, including dosage, side effects, cost, and safety info.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2026-05-12T21:44:12+00:00","article_modified_time":"2026-05-12T21:53:09+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg","type":"image\/jpeg"}],"author":"Dr. Mark Alfonso, PharmD, BCMTMS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Mark Alfonso, PharmD, BCMTMS","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/"},"author":{"name":"Dr. Mark Alfonso, PharmD, BCMTMS","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310"},"headline":"Sevenfact: A New Treatment Option for Hemophilia With Inhibitors","datePublished":"2026-05-12T21:44:12+00:00","dateModified":"2026-05-12T21:53:09+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/"},"wordCount":1020,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg","keywords":["Dr. Mark Alfonso"],"articleSection":["Hemophilia"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/","name":"Sevenfact: Una nueva opci\u00f3n de tratamiento para la hemofilia con inhibidores - AmeriPharma\u00ae Specialty Care","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg","datePublished":"2026-05-12T21:44:12+00:00","dateModified":"2026-05-12T21:53:09+00:00","description":"Inf\u00f3rmese sobre Sevenfact, un tratamiento aprobado por la FDA para la hemofilia A o B con inhibidores, incluyendo informaci\u00f3n sobre la dosis, los efectos secundarios, el costo y la seguridad.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg","width":1280,"height":853,"caption":"Doctor seeing a boy and parent about hemophilia and Sevenfact"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/sevenfact-a-new-treatment-option-for-hemophilia-with-inhibitors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Sevenfact: A New Treatment Option for Hemophilia With Inhibitors"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310","name":"Dr. Mark Alfonso, PharmD, BCMTMS","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","caption":"Dr. Mark Alfonso, PharmD, BCMTMS"},"description":"El Dr. Mark Alfonso, doctor en farmacia, naci\u00f3 y creci\u00f3 en Pueblo, Colorado. Obtuvo su t\u00edtulo en farmacia en la Facultad de Farmacia de la Universidad de Colorado, en el Campus M\u00e9dico Anschutz, en 2010. Obtuvo su certificaci\u00f3n en gesti\u00f3n de terapias farmacol\u00f3gicas en 2022. Lo m\u00e1s gratificante de su trabajo es ayudar a responder las preguntas e inquietudes de los pacientes. Sus \u00e1reas de especializaci\u00f3n son la farmacia comunitaria y la gesti\u00f3n de terapias farmacol\u00f3gicas. En su tiempo libre, disfruta de la lectura y correr.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"uagb_comment_info":0,"uagb_excerpt":"Sevenfact is an FDA-approved medication used to treat or control bleeding in patients with hemophilia A or B with inhibitors. In this article, you will learn about its mechanism of action, dosage, side effects, cost, and more.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2026\/05\/doctor-hemophilia.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/mark-alfonso\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/hemophilia\/\" rel=\"category tag\">Hemophilia<\/a>","rttpg_excerpt":"Sevenfact is an FDA-approved medication used to treat or control bleeding in patients with hemophilia A or B with inhibitors. In this article, you will learn about its mechanism of action, dosage, side effects, cost, and more.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/28285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=28285"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/28285\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/28286"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=28285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=28285"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=28285"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}